How has Pfizer's collateral already posted, aggregate fair value changed year-over-year?

Pfizer's collateral already posted, aggregate fair value increased by 87.5% year-over-year, from $640M to $1.2B.

Pfizer PFE Collateral already posted, aggregate fair value

Collateral already posted, aggregate fair value at other companies

LFT

Lument Finance TrustLFT

$0-100%

Phillips 66PSX

$827M+209%

BKBK

$611M+94.0%

State StreetSTT

$2.2B+30.7%

LFT

Lument Finance TrustLFT

$985.67M+32.7%

BKBK

$126M-49.6%

Other financials

Income statement

See full

Revenue$14.5B+5.4%

Gross profit$10.9B+0.3%

Net income$2.7B-9.4%

EPS (diluted)$0.47-9.6%

Balance sheet

See full

Cash & equivalents$1.8B+18.8%

Total debt$64.4B+5.0%

Total equity$90.1B-0.3%

Total assets$207.62B-0.2%

Cash flow

See full

Operating cash flow$2.6B+12.0%

CapEx$436.0M-22.7%

Free cash flow$2.2B+23.0%

Valuation

See full

Market cap$143.68B+11.1%

Enterprise value$206.35B+9.2%

P/E11.9×—

P/S2.3×+0.2×

Profitability

See full

Gross margin73.5%+1.2pp

Net margin15.7%—

Returns & leverage

See full

Return on equity10.6%—

Debt / equity0.7×0.0×

Current ratio1.2×0.0×

Where this comes from

Reported directly by Pfizer in its filing.

Tagged under the XBRL concept us-gaap:CollateralAlreadyPostedAggregateFairValue.

The official record: Pfizer’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →

Ask your AI about Pfizer's collateral already posted, aggregate fair value.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Pfizer's collateral already posted, aggregate fair value?: Pfizer (PFE) reported collateral already posted, aggregate fair value of $1.2B in Q1 2026.
How has Pfizer's collateral already posted, aggregate fair value changed year-over-year?: Pfizer's collateral already posted, aggregate fair value increased by 87.5% year-over-year, from $640M to $1.2B.